You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Apolipoprotein A-I (APOA1) Antibodies

Full name:
anti-Apolipoprotein A-I Antibodies (APOA1)
On www.antibodies-online.com are 538 Apolipoprotein A-I (APOA1) Antibodies from 35 different suppliers available. Additionally we are shipping Apolipoprotein A-I Kits (98) and Apolipoprotein A-I Proteins (97) and many more products for this protein. A total of 755 Apolipoprotein A-I products are currently listed.
Synonyms:
Alp-1, Apo-AI, apoa, Apoa-1, apoA-I, apoa1, ApoAI, Brp-14, cb49, LOC100136573, Ltw-1, Lvtw-1, MGC64335, MGC89745, Sep-1, Sep-2, Sep2, wu:fb33f01, zgc:103718
list all antibodies Gene Name GeneID UniProt
APOA1 335 P02647
APOA1 11806 Q00623
APOA1 25081 P04639

Show all species

Show all synonyms

All available anti-Apolipoprotein A-I Antibodies

Go to our pre-filtered search.

Top referenced anti-Apolipoprotein A-I Antibodies

  1. Human Polyclonal APOA1 Primary Antibody for IHC (p), IP - ABIN152915 : Vedhachalam, Duong, Nickel, Nguyen, Dhanasekaran, Saito, Rothblat, Lund-Katz, Phillips: Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. in The Journal of biological chemistry 2007 (PubMed)
    Show all 4 references for ABIN152915

  2. Mouse (Murine) Monoclonal APOA1 Primary Antibody for WB - ABIN968823 : Cuthbert, Wang, Zhang, Tam: Regulation of human apolipoprotein A-I gene expression by gramoxone. in The Journal of biological chemistry 1997 (PubMed)
    Show all 2 references for ABIN968823

  3. Human Monoclonal APOA1 Primary Antibody for EIA, WB - ABIN950461 : Dastani, Dangoisse, Boucher, Desbiens, Krimbou, Dufour, Hegele, Pajukanta, Engert, Genest, Marcil: A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians. in Atherosclerosis 2006 (PubMed)
    Show all 2 references for ABIN950461

  4. Human Monoclonal APOA1 Primary Antibody for ELISA, WB - ABIN1724693 : Brown, Rea, Hamon, Hixson, Boerwinkle, Clark, Sing: The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability. in Journal of molecular medicine (Berlin, Germany) 2006 (PubMed)
    Show all 2 references for ABIN1724693

  5. Rat (Rattus) Monoclonal APOA1 Primary Antibody for WB - ABIN968824 : Poncin, Martial, Gielen: Cloning and structure analysis of the rat apolipoprotein A-I cDNA. in European journal of biochemistry / FEBS 1984 (PubMed)
    Show all 2 references for ABIN968824

  6. Human Monoclonal APOA1 Primary Antibody for EIA, RIA - ABIN111352 : Jamil, Gordon, Eustice, Brooks, Dickson, Chen, Ricci, Chu, Harrity, Ciosek, Biller, Gregg, Wetterau: An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells. in Proceedings of the National Academy of Sciences of the United States of America 1996 (PubMed)
    Show all 2 references for ABIN111352

  7. Human Polyclonal APOA1 Primary Antibody for EIA, IHC (fro) - ABIN116540 : Bernthaler, Epping, Schmitz, Deplazes, Brehm: Molecular characterization of EmABP, an apolipoprotein A-I binding protein secreted by the Echinococcus multilocularis metacestode. in Infection and immunity 2009 (PubMed)

  8. Human Polyclonal APOA1 Primary Antibody for EIA, IHC (p) - ABIN359573 : Simó, Higuera, García-Ramírez, Canals, García-Arumí, Hernández: Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. in Archives of ophthalmology 2008 (PubMed)

  9. Chicken Polyclonal APOA1 Primary Antibody for EIA, WB - ABIN783514 : Zhu, Wu, Zeng, Xue, Chen: Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties. in Journal of lipid research 2005 (PubMed)

  10. Human Polyclonal APOA1 Primary Antibody for EIA, IF - ABIN499311 : Sorci-Thomas, Prack, Dashti, Johnson, Rudel, Williams: Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. in Journal of lipid research 1990 (PubMed)

More Antibodies against Apolipoprotein A-I Interaction Partners

Human Apolipoprotein A-I (APOA1) interaction partners

  1. ABCA1 (show ABCA1 Antibodies) mediates ApoA-I and ApoA-I mimetic peptide mobilization of extracellular cholesterol microdomains deposited by macrophages.

  2. We found inverse independent correlations between metabolic clearance rate of insulin (show INS Antibodies) (MCRI) and hepatic lipase (show LIPC Antibodies) (P = 0.0004), insulin (show INS Antibodies) secretion (P = 0.0002), alanine aminotransferase (show ALT Antibodies) (P = 0.0045), total fat mass (P = 0.014), and diabetes (P = 0.03). MCRI and apolipoprotein A-I exhibited a positive independent correlation (P = 0.035).

  3. Anacetrapib treatment increases HDL (show HSD11B1 Antibodies) apoA-I and CETP (show CETP Antibodies) levels by decreasing the fractional clearance rate of each protein

  4. Our findings confirm a causal association of APOA1 with gout.

  5. Epidemiological and functional studies underline a prognostic value of ApoA1 self-antibodies for several cardiovascular diseases. Review.

  6. ApoA-I is inversely associated with insulin (show INS Antibodies) resistance in patients with impaired glucose tolerance, and low apoA-I is an independent risk factor for impaired glucose tolerance (IGT). These results indicate that apoA-I plays an important role in regulating insulin (show INS Antibodies) sensitivity and glucose metabolism in patients with IGT.

  7. Results suggest that Apo (show C9orf3 Antibodies)-A1 plays a protective role in inflammatory reaction and might be a predictor for severity of gout and therapeutic target

  8. the initial rapid aggregation of LDL(-) is apparently counterbalanced by the stabilizing effects of minor proteins such as apoA-I and apoJ (show CLU Antibodies). These results help identify key determinants for LDL aggregation, fusion and coalescence into lipid droplets in vivo.

  9. structure and function of ApoA-I

  10. Apo A (show APOA Antibodies)-I and paraoxonase-1 (show PON1 Antibodies) levels may be clinically useful for ischemic stroke diagnosis and for differentiating between ischemic and hemorrhagic strokes.

Mouse (Murine) Apolipoprotein A-I (APOA1) interaction partners

  1. Reductions in Dio1 (show DIO1 Antibodies) expression reduce the expression of ApoA-I in a 3,5,3'-triiodothyronine-/thyroid hormone (show PTH Antibodies) response element-independent manner.

  2. apoA-1 deficiency generates changes in the bone cell precursor population that increase adipoblast, and decrease osteoblast production resulting in reduced bone mass and impaired bone quality

  3. This study suggests that enhancement of macrophage cholesterol metabolism by PPARgammais not contributed by activating ABCA1 (show ABCA1 Antibodies) expression and ABCA1 (show ABCA1 Antibodies)-mediated cholesterol efflux to apoAI, which is not involved by CD36 (show CD36 Antibodies) expression either.

  4. Mass spectrometry analysis of peptides derived from chemically crosslinked HDL (show HSD11B1 Antibodies)-SAA (show SAA1 Antibodies) particles detected multiple crosslinks between apoA1 and SAA (show SAA1 Antibodies), indicating close proximity (within 25 A) of these two proteins on the HDL (show HSD11B1 Antibodies) surface, providing a molecular and structural mechanism for the simultaneous binding of heparin to apoA1 and SAA (show SAA1 Antibodies).

  5. results demonstrate that double deletion of Apoe (show APOE Antibodies) and Apoa1 ameliorated the amyloid pathology.

  6. study suggests that apolipoprotein a1 can alleviate obesity related metabolic disease by inducing AMPK (show PRKAA1 Antibodies) dependent mitochondrial biogenesis.

  7. ApoA-I can attenuate lymphocyte activation and autoimmunity in Lupus independently of cholesterol transport, through oxidized fatty acid peroxisome proliferator-activated receptor gamma (show PPARG Antibodies) ligands, and it can reduce renal inflammation in glomerulonephritis.

  8. KLF14 (show SP6 Antibodies) regulates plasma HDL (show HSD11B1 Antibodies)-C levels and cholesterol efflux capacity by modulating hepatic ApoA-I production.

  9. Akt (show AKT1 Antibodies), through its downstream targets, mTORC1 and hence autophagy, negatively regulates cholesterol efflux to apoA-I.

  10. macrophage apoAI expression protects against atherosclerosis and dermatitis by reducing cholesterol accumulation and regulating CD4 (show CD4 Antibodies)(+) T-cell levels, without affecting serum HDL (show HSD11B1 Antibodies) or tissue macrophage levels.

Pig (Porcine) Apolipoprotein A-I (APOA1) interaction partners

  1. Alterations in the Apo A (show APOA Antibodies)-I pattern is a good indicator of the presence and severity of infectious diseases in the pig.Lower overall amounts of Apo A (show APOA Antibodies)-I were observed in Salmonella typhimurium and Escherichia coli infections.

  2. down-regulation of apolipoprotein A-I and A-IV messages in the liver may be mediated by interleukin 6 (show IL6 Antibodies) and tumor necrosis factor-alpha (show TNF Antibodies)

Rabbit Apolipoprotein A-I (APOA1) interaction partners

  1. This study showed that apoA-I exerted protective effects against fatty liver disease in rabbits induced by a high-fat diet, possibly through its antioxidant actions.

  2. The molar ratio ApoE (show APOE Antibodies)/ApoA-I is negatively correlated with the enzyme activity, and positively correlated with increases in the intima-media thickness of common carotid wall and cardiac dysfunction signs.

Cow (Bovine) Apolipoprotein A-I (APOA1) interaction partners

  1. Binding of apoA-I to ectopic F(0)F(1) ATPase (show ATP5E Antibodies) triggers the generation of ADP, which via activation of the purinergic receptor P2Y (show P2RY1 Antibodies)(12) stimulates the uptake and transport of HDL (show HSD11B1 Antibodies) and initially lipid-free apoA-I by endothelial cells.

  2. the model of a two-step process for the transendothelial transport of apoA-I in which apoA-I is initially lipidated by ABCA1 (show ABCA1 Antibodies) and then further processed by ABCA1 (show ABCA1 Antibodies)-independent mechanisms.

Zebrafish Apolipoprotein A-I (APOA1) interaction partners

  1. insulin (show INS Antibodies) secretion and tissue rejuvenation activities of WT-reconstituted high-density lipoproteins were nearly depleted by fructosylation, but V156K-rHDL did not lose its beneficial activity.

  2. The NABB system using engineered zebrafish apo A-I is a native-like membrane mimetic system for G-protein-coupled receptors.

Apolipoprotein A-I (APOA1) Antigen Profile

Antigen Summary

This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis.

Alternative names and synonyms associated with Apolipoprotein A-I (APOA1)

  • apolipoprotein A-I (APOA1) antibody
  • apolipoprotein A-I-like (LOC100386212) antibody
  • apolipoprotein A-I (apoa1) antibody
  • apolipoprotein A-I (apoa-i) antibody
  • apolipoprotein A-I (LOC100136573) antibody
  • apolipoprotein A-I (Apoa1) antibody
  • apolipoprotein A-I (APOAI) antibody
  • apolipoprotein A-Ia (apoa1a) antibody
  • Alp-1 antibody
  • Apo-AI antibody
  • apoa antibody
  • Apoa-1 antibody
  • apoA-I antibody
  • apoa1 antibody
  • ApoAI antibody
  • Brp-14 antibody
  • cb49 antibody
  • LOC100136573 antibody
  • Ltw-1 antibody
  • Lvtw-1 antibody
  • MGC64335 antibody
  • MGC89745 antibody
  • Sep-1 antibody
  • Sep-2 antibody
  • Sep2 antibody
  • wu:fb33f01 antibody
  • zgc:103718 antibody

Protein level used designations for APOA1

apolipoprotein A-I , apolipoprotein A-I-like , apolipoprotein A-I preproprotein , apo-AI , apoA-I , apolipoprotein A1 , apolipoprotein A-1 , preproapolipoprotein A-I , Apolipoprotein A1 , Apolipoprotein A-I , etID309895.5 , etID32161.5

GENE ID SPECIES
425629 Gallus gallus
696969 Macaca mulatta
100386212 Callithrix jacchus
100528199 Ictalurus punctatus
379421 Xenopus laevis
448709 Xenopus (Silurana) tropicalis
778012 Takifugu rubripes
100126737 Papio anubis
100136573 Salmo salar
335 Homo sapiens
11806 Mus musculus
397691 Sus scrofa
100009253 Oryctolagus cuniculus
25081 Rattus norvegicus
396536 Gallus gallus
281631 Bos taurus
479427 Canis lupus familiaris
443373 Ovis aries
281632 Bos taurus
100454832 Pongo abelii
451564 Pan troglodytes
100196111 Salmo salar
101841336 Mesocricetus auratus
30355 Danio rerio
Selected quality suppliers for anti-Apolipoprotein A-I (APOA1) Antibodies
Did you look for something else?